According to the data reported previously, MALAT1 can be used as a promisingbiomarker in the clinical diagnosis and prognosis of aggressive breast cancer.Findings on the MALAT1 expression level can be a prognostic factor. This evidence concerns the gene MALAT1 and breast carcinoma.